BEGIN:VCALENDAR
VERSION:2.0
PRODID:IEEE vTools.Events//EN
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
DTSTART:20260308T030000
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:EDT
END:DAYLIGHT
BEGIN:STANDARD
DTSTART:20261101T010000
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:EST
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20260311T195824Z
UID:6F045C8B-5EE2-4EE6-8870-1E2E3FEA871A
DTSTART;TZID=America/New_York:20260311T143000
DTEND;TZID=America/New_York:20260311T153000
DESCRIPTION:Every year\, over one million people in the U.S. rush to the em
 ergency room after experiencing their first seizure or seizure-like event.
  For many\, the journey that follows is frustrating and uncertain. Epileps
 y is notoriously difficult to diagnose - so much so that nearly 30% of pat
 ients receive the wrong diagnosis. The most common mistake? Being told the
 y have epilepsy when they do not. These misdiagnosed patients spend months
  or even years trying ineffective medications\, enduring unnecessary side 
 effects\, and living with the fear of seizures they don’t actually have 
 only to later discover they have a completely different condition. Why is 
 diagnosing epilepsy so difficult? Unlike other diseases\, there has been n
 o reliable biomarker. Our team has identified an EEG-based biomarker for e
 pilepsy\, a game-changing discovery that is currently being tested in thre
 e major epilepsy centers across the U.S. This new tool\, EpiScalp\, has th
 e potential to revolutionize epilepsy diagnosis\, ensuring patients receiv
 e the right answers and the right treatment from their very first visit to
  a neurologist.\n\nSpeaker(s): Sridevi Sarma\, PhD - EMBS Distinguished Le
 cturer\n\nVirtual: https://events.vtools.ieee.org/m/537663
LOCATION:Virtual: https://events.vtools.ieee.org/m/537663
ORGANIZER:steve.mozelewski@gmail.com
SEQUENCE:14
SUMMARY:A Scalp-EEG Tool for Epilepsy Diagnosis: Getting Patients the Right
  Answers\, Faster
URL;VALUE=URI:https://events.vtools.ieee.org/m/537663
X-ALT-DESC:Description: <br /><p class="MsoNormal" style="margin-bottom: 0i
 n\; text-align: justify\; line-height: normal\;"><span style="font-size: 1
 2.0pt\; font-family: 'Times New Roman'\,serif\; mso-fareast-font-family: '
 Times New Roman'\; color: black\; mso-themecolor: text1\;">Every year\, ov
 er&nbsp\;one million&nbsp\;people in the U.S. rush to the emergency room a
 fter experiencing their first seizure or seizure-like event. For many\, th
 e journey that follows is frustrating and uncertain. Epilepsy is notorious
 ly difficult to diagnose - so much so that nearly&nbsp\;30% of patients&nb
 sp\;receive the wrong diagnosis. The most common mistake? Being told they 
 have epilepsy when they do not. These misdiagnosed patients spend&nbsp\;mo
 nths or even years&nbsp\;trying ineffective medications\, enduring unneces
 sary side effects\, and living with the fear of seizures they don&rsquo\;t
  actually have only to later discover they have a completely different con
 dition. Why is diagnosing epilepsy so difficult? Unlike other diseases\, t
 here has been&nbsp\;no reliable biomarker. Our team has identified an EEG-
 based biomarker for epilepsy\, a game-changing discovery that is currently
  being tested in three major epilepsy centers across the U.S. This new too
 l\,&nbsp\;EpiScalp\, has the potential to&nbsp\;revolutionize epilepsy dia
 gnosis\, ensuring patients receive the right answers and the right treatme
 nt&nbsp\;from their very first visit to a neurologist.</span></p>
END:VEVENT
END:VCALENDAR